- Home
- RXRX vs SKWD Comparison
RXRX vs SKWD Comparison
Compare RXRX & SKWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RXRX
- SKWD
- Stock Information
- Founded
- RXRX 2013
- SKWD 2007
- Country
- RXRX United States
- SKWD United States
- Employees
- RXRX N/A
- SKWD N/A
- Industry
- RXRX Biotechnology: Pharmaceutical Preparations
- SKWD Property-Casualty Insurers
- Sector
- RXRX Health Care
- SKWD Finance
- Exchange
- RXRX Nasdaq
- SKWD Nasdaq
- Market Cap
- RXRX 2.6B
- SKWD 2.3B
- IPO Year
- RXRX 2021
- SKWD 2023
- Fundamental
- Price
- RXRX $6.05
- SKWD $46.34
- Analyst Decision
- RXRX Buy
- SKWD Buy
- Analyst Count
- RXRX 4
- SKWD 13
- Target Price
- RXRX $7.25
- SKWD $62.64
- AVG Volume (30 Days)
- RXRX 70.2M
- SKWD 470.7K
- Earning Date
- RXRX 11-10-2025
- SKWD 10-29-2025
- Dividend Yield
- RXRX N/A
- SKWD N/A
- EPS Growth
- RXRX N/A
- SKWD 6.84
- EPS
- RXRX N/A
- SKWD 3.16
- Revenue
- RXRX $64,596,000.00
- SKWD $1,253,720,000.00
- Revenue This Year
- RXRX $24.17
- SKWD $17.72
- Revenue Next Year
- RXRX $20.96
- SKWD $15.95
- P/E Ratio
- RXRX N/A
- SKWD $14.65
- Revenue Growth
- RXRX 30.14
- SKWD 21.67
- 52 Week Low
- RXRX $3.79
- SKWD $41.28
- 52 Week High
- RXRX $12.36
- SKWD $65.05
- Technical
- Relative Strength Index (RSI)
- RXRX 55.40
- SKWD 44.51
- Support Level
- RXRX $5.58
- SKWD $45.82
- Resistance Level
- RXRX $7.18
- SKWD $47.39
- Average True Range (ATR)
- RXRX 0.66
- SKWD 1.42
- MACD
- RXRX -0.01
- SKWD -0.12
- Stochastic Oscillator
- RXRX 49.05
- SKWD 28.15
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
About SKWD Skyward Specialty Insurance Group Inc.
Skyward Specialty Insurance Group Inc is a specialty insurance company that delivers commercial property and casualty products and solutions on a non-admitted and admitted basis. The firm has one reportable segment through which it offers a broad array of insurance coverages to several market niches. It operates multiple lines of business, including general liability, excess liability, professional liability, commercial auto, group accident, health, property, surety, and workers' compensation.